NovaBay Pharmaceuticals (NYSE:NBY) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Stock Performance NBY stock opened at $0.08 on Tuesday. NovaBay Pharmaceuticals has a 1 year low of $0.07 and a 1 year high […]

Related Keywords

United States , ,Novabay Pharmaceuticals ,Novabay Pharmaceuticals Stock Performance ,Novabay Pharmaceuticals Inc ,News Ratings For Novabay Pharmaceuticals Daily ,Armistice Capital ,Free Report ,Bay Pharmaceuticals ,Get Free Report ,Avenova Spray ,Novabay Pharmaceuticals Daily ,Nyse Nby ,Anby ,Medical ,Initiated Coverage ,Stocknews Com ,